Online citations, reference lists, and bibliographies.
← Back to Search

Microcrystals For Dissolution Rate Enhancement Of Poorly Water-soluble Drugs.

N. Rasenack, H. Hartenhauer, B. Mueller
Published 2003 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Slight dissolution rates related to poor water-solubility are one of the well-known difficulties to be covered during the development of new drug substances. The poorly water-soluble drug ECU-01, a low molecular enzyme-inhibitor with anti-inflammatory properties for oral administration, shows a poor dissolution rate. This study is intended to enhance the drug dissolution rate by using microcrystals. The common way for micronization is the milling of previously formed larger crystals. However, milling shows several disadvantages as the newly created surfaces are thermodynamically activated due to the high energy input and not naturally grown. In this study microcrystals were not produced using any cutting up techniques, but only by association. Naturally grown microcrystals were prepared by a precipitation method in the presence of stabilizing agents (e.g. gelatin, chitosan, different types of cellulose ethers) followed by spray-drying of the formed dispersion. First the drug was dissolved in acetone and then precipitated by rapid pouring an aqueous solution of the stabilizer into the drug solution. Particularly, cellulose ethers were able to form stable and homogeneous dispersions of microcrystals (mean particle size = 1 microm) showing a tight particle size distribution. By spray-drying, the drug powder was obtained. The dissolution rate is significantly enhanced (common drug: 4% after 20 min/microcrystals 93% after 20 min) due to the large surface, which is hydrophilized by adsorbed stabilizers as shown by the decreased contact angle (65 and 30 degrees, respectively).
This paper references
10.1016/S0378-5173(98)00179-3
Determination of surface properties and flow characteristics of salbutamol sulphate, before and after micronisation
J. C. Feeley (1998)
Micronization: a method of improving the bioavailability of poorly soluble drugs.
Chaumeil Jc (1998)
10.1002/JPS.2600600902
Pharmaceutical applications of solid dispersion systems.
W. Chiou (1971)
10.1021/JS980403L
Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs.
A. T. Serajuddin (1999)
10.1016/S0378-5173(99)00347-6
Characterisation of the influence of micronisation on the crystallinity and physical stability of revatropate hydrobromide.
M. Ticehurst (2000)
10.1016/S0378-5173(98)00247-6
Characterisation of the surface energetics of milled dl-propranolol hydrochloride using inverse gas chromatography and molecular modelling
P. York (1998)
10.1002/jps.2600650641
Remington's pharmaceutical sciences
J. P. Remington (1985)
10.1016/S0169-409X(97)00507-3
Characterisation of small changes in the physical properties of powders of significance for dry powder inhaler formulations.
Buckton (1997)
10.1016/0378-5173(83)90159-X
Adsorption of non-ionic water-soluble cellulose polymers at the solid-water interface and their effect on suspension stability
Stephen L. Law (1983)
Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form.
M. Cospite (1989)
10.1016/S0378-5173(02)00294-6
Ibuprofen crystals with optimized properties.
N. Rasenack (2002)
10.1023/A:1016232230638
Process-Induced Crystallinity Changes in Albuterol Sulfate and Its Effect on Powder Physical Stability
G. Ward (2004)
10.1002/APMC.1989.051660110
Preparation and characterization of microdisperse bioavailable carotenoid hydrosols
D. Horn (1989)
10.1016/S0378-5173(99)00063-0
Micronization of drugs using supercritical carbon dioxide.
J. Kerč (1999)
Pharmacopoeial cellulose ethers as oil-in-water emulsifiers. I: Interfacial properties
Rolf Daniels (1994)
10.1016/S0378-5173(99)00412-3
Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide.
C. Jacobs (2000)
10.1016/S0169-409X(00)00118-6
Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.
R. Mueller (2001)
10.1023/A:1007576713216
A Comparison of the Solubility of Danazol in Human and Simulated Gastrointestinal Fluids
B. L. Pedersen (2004)
10.1023/A:1015909716312
In Vitro Dissolution Profile of Water-Insoluble Drug Dosage Forms in the Presence of Surfactants
V. Shah (2004)
Hydrosols : alternatives for the parenteral application of poorly water soluble drugs
P. Gassmann (1994)
10.1016/S0939-6411(00)00091-6
Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards.
R. Löbenberg (2000)
10.1016/S0378-5173(97)00071-9
Micronizing of steroids for pulmonary delivery by supercritical carbon dioxide
H. Steckel (1997)
Nanosuspensionen - Formulierungen für schwerlösliche Arzneistoffe mit geringer Bioverfügbarkeit. 1. Mitteilung: Herstellung und Eigenschaften
R. Mueller (1999)
10.1016/0378-5173(94)00364-B
The use of amorphous model substances to study mechanically activated materials in the solid state
A. A. Elamin (1995)
10.1016/0021-9797(78)90010-3
The surface tension of aqueous hydroxypropyl cellulose solutions
S. Chang (1978)



This paper is referenced by
10.1208/s12249-011-9697-8
Dissolution and Solid-State Characterization of Poorly Water-Soluble Drugs in the Presence of a Hydrophilic Carrier
R. Talukder (2011)
10.1208/s12249-010-9505-x
Enhancement of Bioavailability of Cefpodoxime Proxetil Using Different Polymeric Microparticles
Fahim Khan (2010)
International Journal for Pharmaceutical Research Scholars (IJPRS)
Thakare Sp (2014)
Nanotechnology:Size Reduction Technologies in the Pharmaceutical Development Process
J. Möschwitzer (2010)
10.1039/C0MD00093K
The kinetics of bulk hydration of the disaccharides α-lactose and trehalose by in situ neutron powder diffraction
Valeska Ting (2010)
Preparation of composite microparticles for dissolution enhancement of a poorly water-soluble anti-malarial drug
Nanda Gopal Sahoo (2011)
LIQUISOLID TECHNIQUE: A NOVEL APPROACH TO ENHANCE SOLUBILITY AND BIOAVAILABILITY OF BCS - II DRUGS
V. Amrutha (2012)
10.7317/PK.2012.36.1.041
Preparation and Characterization of Poly(ethylene glycol) Based Pranlukast Solid Dispersion
Hyeong Eun Kim (2012)
10.9734/JPRI/2017/36872
Solubility Enhancement of a BCS Class II Drug Using Granulated Fumed Silica as an Adsorbent
Sawani D. Talekar (2017)
10.1002/9781118451915.CH37
Nanometric‐Size Delivery Systems for Bioactive Compounds for the Nutraceutical and Food Industries
F. Donsì (2013)
10.1002/mabi.201600228
Layer-by-Layer Coating of Solid Drug Cores: A Versatile Method to Improve Stability, Control Release and Tune Surface Properties.
Anna K Polomska (2017)
10.1016/j.ijbiomac.2018.09.184
Fabrication and in vitro characterization of HPMC-g-poly(AMPS) hydrogels loaded with loxoprofen sodium.
Hira Khanum (2018)
10.1016/j.ejpb.2008.02.014
Dissolution rate enhancement of the novel antitumoral beta-lapachone by solvent change precipitation of microparticles.
M. S. S. Cunha-Filho (2008)
10.1002/jps.21399
Solubility enhancement of a poorly water-soluble anti-malarial drug: experimental design and use of a modified multifluid nozzle pilot spray drier.
N. G. Sahoo (2009)
10.1007/978-3-642-00477-3_12
Improving oral delivery.
F. Gabor (2010)
10.1208/s12249-013-9957-x
Influence of Microcrystal Formulation on In Vivo Absorption of Celecoxib in Rats
M. Nasr (2013)
10.1007/s11095-008-9560-0
What is a Suitable Dissolution Method for Drug Nanoparticles?
Desmond Heng (2008)
10.1007/s12272-011-0115-2
Solid dispersion formulations of megestrol acetate with copovidone for enhanced dissolution and oral bioavailability
Soon Wook Hong (2011)
10.5151/CHEMENG-COBEQIC2015-114-32308-245635
AVALIAÇÃO DO PERFIL DE DISSOLUÇÃO DA GLIBENCLAMIDA CRISTALIZADA POR PROCESSO DE PRECIPITAÇÃO COM ANTISSOLVENTE LÍQUIDO
M. C. Abrantes (2015)
Micro/nanonisation du naproxène et du dipropionate de béclométhasone en milieu aqueux par fragmentation laser femtoseconde
Weimeng Ding (2011)
The production and characterisation of itraconazole multicomponent systems
Agnieszka Kozyra (2019)
10.1007/s13346-019-00659-6
Optimising the release rate of naproxen liqui-pellet: a new technology for emerging novel oral dosage form
M. Lam (2019)
10.1016/J.APT.2016.05.026
A study of the impact of polymer–surfactant in drug nanoparticle coated pharmatose composites on dissolution performance
M. Li (2016)
10.1111/j.2042-7158.2010.01022.x
Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods
L. Peltonen (2010)
10.1007/s11095-011-0428-3
Formulation, Biological and Pharmacokinetic Studies of Sucrose Ester-Stabilized Nanosuspensions of Oleanolic Acid
Wenji Li (2011)
10.1016/j.ejpb.2010.06.016
Enhancement of dissolution rate and oral absorption of a poorly water-soluble drug, K-832, by adsorption onto porous silica using supercritical carbon dioxide.
H. Miura (2010)
PREPARATION AND EVALUATION OF MICROCRYSTALS OF CEFUROXIME AXETIL
Nighute (2009)
10.1016/J.POWTEC.2010.05.019
Fabrication of composite microparticles of artemisinin for dissolution enhancement
N. G. Sahoo (2010)
10.34172/ps.2019.52
Response Surface Methodology for Optimization of Process Variables of Atorvastatin Suspension Preparation by Microprecipitation Method Using Desirability Function
M. Maghsoodi (2020)
APPLICATION OF SOME NOVEL TECHNIQUES FOR SOLUBILITY ENHANCEMENT OF MEFENAMIC ACID, A POORLY WATER SOLUBLE DRUG
S. Kumar (2009)
SPHERICAL CRYSTALLIZATION: A TOOL OF PARTICLE ENGINEERING FOR MAKING DRUG POWDER SUITABLE FOR DIRECT COMPRESSION
Man Mohan Gupta (2010)
10.1016/j.ijpharm.2011.08.003
Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat.
Xue-qing Wang (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar